In Brief: PMAs for obsolete devices
This article was originally published in The Gray Sheet
Executive Summary
PMAs for obsolete devices: FDA issues proposed call for PMAs for 43 "disused" preamendments Class III devices in a Sept. 7 Federal Register notice. FDA does not expect any viable premarket approval applications or petitions for reclassification to be submitted because the devices have fallen into disuse. Comments on the proposal are due Jan. 5, 1996, and requests for reclassification of the devices are due Sept. 22. FDA initially identified the devices in an announcement in the May 6, 1994 Federal Register ("The Gray Sheet" May 9, p. 14)...
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.